markets and out-licenses patented Pharmaceutical Formulations, NDDS, niche API’s and chiral intermediates.
KLab’s major sales are
from patented products from in-house R&D. Cefi-XL our patented antibiotic combination is the No.1 launched new
product in India in last 2 years as per July 2006 IMS report.
KLab has more than 150
patents granted/pending using NDDS,
Nanotechnology, Dendrimers and Chiral Chemistry.
KLab is ranked 57th in
the Indian Pharmaceutical Industry
As per IMS ORG, & KLab is ranked 26th as per its covered market and is growing
above 30% per annum. Within next 3 years, KLab plans to be around
number 10th rank in its covered market.
KLab has over 2000
The sales force comprises around 1500 persons who cover 250,000 Doctors, 100,000 Pharmacies and
1500 Stockists in India every month.
KLab has a unique
intelligent monthly incentive system
more than 60% of its sales persons to earn more than 50% of
by way of incentives.
KLab has launched six
operating in different therapeutic areas, to
enable focus on maximum new product launches.
We thank you for your interest in Khandelwal
You can apply against a specific open position.
You can do this by looking for the position in the
specified functional areas in the "Current Job Openings"
In the absence of a job posting, you can also apply
spontaneously by going to the "Apply Directly" Link.
Your data will be entered into our
database and you will be contacted if your profile
matches any of our available positions